MX2021015879A - Peptidos restringidos. - Google Patents
Peptidos restringidos.Info
- Publication number
- MX2021015879A MX2021015879A MX2021015879A MX2021015879A MX2021015879A MX 2021015879 A MX2021015879 A MX 2021015879A MX 2021015879 A MX2021015879 A MX 2021015879A MX 2021015879 A MX2021015879 A MX 2021015879A MX 2021015879 A MX2021015879 A MX 2021015879A
- Authority
- MX
- Mexico
- Prior art keywords
- constrained peptides
- peptides
- constrained
- kits
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Esta solicitud se refiere generalmente a sales restringidas de péptidos, formas restringidas de péptidos, y composiciones, kits, métodos de uso, o usos de los mismos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962863651P | 2019-06-19 | 2019-06-19 | |
US201962863666P | 2019-06-19 | 2019-06-19 | |
PCT/US2020/038205 WO2020257327A1 (en) | 2019-06-19 | 2020-06-17 | Constrained peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021015879A true MX2021015879A (es) | 2022-07-04 |
Family
ID=74040887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021015879A MX2021015879A (es) | 2019-06-19 | 2020-06-17 | Peptidos restringidos. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3986914A4 (es) |
JP (1) | JP2022537383A (es) |
KR (1) | KR20220044719A (es) |
CN (1) | CN114206916A (es) |
AU (1) | AU2020298164A1 (es) |
BR (1) | BR112021025487A2 (es) |
CA (1) | CA3143676A1 (es) |
MX (1) | MX2021015879A (es) |
WO (1) | WO2020257327A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023215269A1 (en) * | 2022-05-06 | 2023-11-09 | The Regents Of The University Of California | Lacripep promotes neuroregeneration and maintains epithelial progenitor cell identity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804539A (en) * | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
WO2011138228A1 (en) * | 2010-05-04 | 2011-11-10 | Trb Chemedica Ag | Aqueous composition for ophthalmic or dermal use |
RU2019126279A (ru) * | 2017-02-21 | 2021-03-23 | Тирсолюшнз, Инк. | Стабильные пептидные композиции |
-
2020
- 2020-06-17 BR BR112021025487A patent/BR112021025487A2/pt unknown
- 2020-06-17 AU AU2020298164A patent/AU2020298164A1/en active Pending
- 2020-06-17 WO PCT/US2020/038205 patent/WO2020257327A1/en unknown
- 2020-06-17 KR KR1020227001822A patent/KR20220044719A/ko unknown
- 2020-06-17 JP JP2021575508A patent/JP2022537383A/ja active Pending
- 2020-06-17 MX MX2021015879A patent/MX2021015879A/es unknown
- 2020-06-17 EP EP20826413.5A patent/EP3986914A4/en active Pending
- 2020-06-17 CA CA3143676A patent/CA3143676A1/en active Pending
- 2020-06-17 CN CN202080056506.8A patent/CN114206916A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3143676A1 (en) | 2020-12-24 |
AU2020298164A1 (en) | 2022-02-03 |
EP3986914A1 (en) | 2022-04-27 |
JP2022537383A (ja) | 2022-08-25 |
EP3986914A4 (en) | 2023-07-19 |
CN114206916A (zh) | 2022-03-18 |
BR112021025487A2 (pt) | 2022-05-17 |
WO2020257327A1 (en) | 2020-12-24 |
KR20220044719A (ko) | 2022-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021014441A (es) | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. | |
MX2021014443A (es) | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. | |
MX2021006154A (es) | Degradadores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos. | |
ZA201906822B (en) | Indole ahr inhibitors and uses thereof | |
MX2020006812A (es) | Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos. | |
PH12019500540A1 (en) | Anti-pd-1 antibodies and their uses | |
MX2022007576A (es) | Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos. | |
MX2020007799A (es) | Inhibidores de cinasa no derrepresible de control de aminoacido general 2 (gcn2) y sus usos. | |
MX2021004245A (es) | Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos. | |
MX2021012216A (es) | Degradadores de transductores de señal y activadores de transcripción (stat) y usos de los mismos. | |
MX2020010951A (es) | Anticuerpos anti-hla-g y utilizacion de los mismos. | |
MX2020001793A (es) | Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos. | |
MX2021008592A (es) | Composiciones de trem y usos de las mismas. | |
EP4112611A3 (en) | Modulators of sestrin-gator2 interaction and uses thereof | |
PH12019501872A1 (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
EP4234552A3 (en) | 3-phosphoglycerate dehydrogenase inhibitors and uses thereof | |
MX2022010755A (es) | Inhibidores de quinasa y usos de los mismos. | |
ZA202309446B (en) | Rapamycin analogs and uses thereof | |
MX2022007841A (es) | Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos. | |
PH12018502233A1 (en) | ErbB INHIBITORS AND USES THEREOF | |
MX2022005091A (es) | Metodos de preparacion de una muestra enriquecida para la secuenciacion de polipeptidos. | |
MX2020006596A (es) | Hidroxiisoxazolinas y derivados de estos. | |
WO2020123816A3 (en) | Anellosomes and methods of use | |
MX2022001449A (es) | Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos. | |
MX2019009759A (es) | Composiciones de peptido estables. |